21230-43-3 Usage
General Description
PYRAZOLE-4-CARBOXYLIC ACID, 3-AMINO-1-METHYL-, ETHYL ESTER is a chemical compound with the molecular formula C8H10N2O2. It is an ethyl ester derivative of pyrazole-4-carboxylic acid and is characterized by the presence of an amino and methyl group. PYRAZOLE-4-CARBOXYLIC ACID, 3-AMINO-1-METHYL-, ETHYL ESTER is commonly used in the pharmaceutical industry for the synthesis of various drugs and bioactive molecules. It has shown potential as a building block for the development of new drugs with therapeutic properties, including anti-inflammatory and antitumor activities. Additionally, it is also used as an intermediate in the production of agrochemicals and veterinary drugs. Its unique structure and properties make it a valuable compound for various chemical and pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 21230-43-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,2,3 and 0 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 21230-43:
(7*2)+(6*1)+(5*2)+(4*3)+(3*0)+(2*4)+(1*3)=53
53 % 10 = 3
So 21230-43-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H11N3O2/c1-3-12-7(11)5-4-10(2)9-6(5)8/h4H,3H2,1-2H3,(H2,8,9)
21230-43-3Relevant articles and documents
Substituted pyrazolopyrimidines
-
Page/Page column 89, (2008/06/13)
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that include substituted heterobicyclic pyrimidines of Formula (I): wherein R1, R2, R3, R4, R5, X, W, and ring A are as defined herein; pharmaceutical compositions of substituted heterobicyclic pyrimidines of Formula (I); and their use in the treatment of chronic neurodegenerative diseases, neurotraumatic diseases, depression and/or diabetes. More particularly, the present invention relates to substituted pyrazolopyrimidines of Formula (I).